Volume 14

Issue 3

Article 13

2006

Voltammetric quantification of fluoxetine: Application to quality
control and quality assurance processes

Follow this and additional works at: https://www.jfda-online.com/journal

Recommended Citation
Lencastre, R.P.; Matos, C.D.; Garrido, J.; Borges, F.; and Garrido, E.M. (2006) "Voltammetric quantification
of fluoxetine: Application to quality control and quality assurance processes," Journal of Food and Drug
Analysis: Vol. 14 : Iss. 3 , Article 13.
Available at: https://doi.org/10.38212/2224-6614.2477

This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been
accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug
Analysis.

242
Journal of Food and Drug Analysis, Vol. 14, No. 3, 2006, Pages 242-246

藥物食品分析

第十四卷

第三期

Voltammetric Quantification of Fluoxetine: Application to
Quality Control and Quality Assurance Processes
RUI P. LENCASTRE1, CRISTINA D. MATOS1, JORGE GARRIDO1,
FERNANDA BORGES2 AND E. MANUELA GARRIDO1*
1.

Department of Chemical Engineering, School of Engineering ISEP, Polytechnic Institute of Porto, Rua S. Tomé, 4200-485 Porto, Portugal.
2.
Research Unit “Molecular Physical-Chemistry”, Department of Organic Chemistry, Faculty of Pharmacy,
University of Porto, 4050-047 Porto, Portugal.
(Received: February 20, 2006; Accepted: June 1, 2006)

ABSTRACT
The oxidative behaviour of fluoxetine was studied at a glassy carbon electrode in various buffer systems and at different pH
using cyclic, differential pulse and square wave voltammetry. A new square wave voltammetric method suitable for the quality
control of fluoxetine in commercial formulations has been developed using a borate pH 9 buffer solution as supporting electrolyte.
Under optimized conditions, a linear response was obtained in the range 10 to 16 μM with a detection limit of 1.0 μM. Validation
parameters such as sensitivity, precision and accuracy were evaluated. The proposed method was successfully applied to the
determination of fluoxetine in pharmaceutical formulations. The results were statistically compared with those obtained by the
reference high-performance liquid chromatographic method. No significant differences were found between the methods.
Key words: Fluoxetine, square wave voltammetry, oxidation, quality control, pharmaceutics.

INTRODUCTION
Depression is a significant and prevalent illness that
has far-reaching effects on patients’ quality of life, survival,
and overall health care utilisation and needs(1).
The class of drugs known as selective serotonin
reuptake inhibitors (SSRIs), which are clinically effective
for the treatment of depression, makes one of the major
medicinal discoveries of the past few decades (2). Their
therapeutic usefulness is still being expanded to include
new indications, such as anxiety and compulsive, post
traumatic stress and pre-menstrual dysphoric disorders(2).
Among SSRIs, f luoxetine, (±)-N-methyl-3-phenyl3-[(α,α,α-trif luoro-p-tolyl)oxy]propyl-amine (Figure
1), has become one of the most commonly prescribed
antidepressant drugs worldwide and as such has received
a great deal of media attention.
Fluoxetine is recommended at an initial daily dose of
20 mg. Caution is advised. A lower or less frequent dose
O
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Figure 1. Structural formulae of fluoxetine.
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should be considered, when fluoxetine is administered to
patients using multiple concomitant medications or with
concurrent disease(3).
The demand for fluoxetine analytical assay is growing
with the increased use of the drug in order to monitor both
compliance and unexpected toxic concentrations after
a chronic use of the drug. Thus, reliable, accurate and
sensitive analytical procedures are needed to determine
the drug levels either in quality control or in therapeutic
drug monitoring.
Several methods for f luoxetine determination have
been reported in the literature. Most of these studies
have determined the concentration of this compound
employing gas-chromatography and high-performance
liquid chromatography (4-6). Official pharmacopoeias,
such as the Br itish Phar macopoeia and the United
States Phar macopoeia (7-8) , repor t the use of liquid
chromatography with UV detection for the determination
of fluoxetine in formulations, capsules and oral solutions.
Spectrophotometric methods and capillary zone
elect rophoresis have also been u sed to deter m i ne
f luoxetine in biological samples and pharmaceutical
formulations(9-12).
Electrochemistry has always provided analytical
techniques characterised by instrumental simplicity,
moderate cost and portability. These features make
electrochemical techniques particularly suitable for the
determination of trace concentrations of biologically and
clinically important compounds(13). Regarding the interest
and widespread use of electrochemical detectors, such as,
in liquid chromatographic systems, it is intriguing that
they had never been used for the analysis and detection
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of f luoxetine although the molecule structure possesses
functional groups susceptible of being oxidable. In view
of this, this study investigated the possibility of using
electrochemical detection to analyse and quantify fluoxetine.
This work aimed to study the voltammetric behaviour
and to establish the experimental conditions for the
determination of fluoxetine using a glassy carbon electrode.
A simple and rapid voltammetric procedure was to be
developed and applied to the determination of fluoxetine in
pharmaceutical dosage forms.

EXPERIMENTAL
I. Materials and Method
Volt a m met r ic me a s u r e me nt s we r e p e r for me d
using an Autolab PGSTAT 10 potentiostat/galvanostat
(EcoChimie, Netherlands) electrochemical analyser. A
glassy carbon working electrode (Metrohm; diameter: 2
mm), an Ag/AgCl reference electrode (Metrohm; 3M KCl),
a glassy carbon rod counter electrode (Metrohm) and a
standard one-compartment three-electrode cell were used
in all experiments. The working electrode was polished
manually with aqueous slurry of alumina powder (BDH)
on a microcloth pad and rinsed with water before use. All
measurements were made at room temperature.
The optimum instrumental parameters to be used
in the square wave voltammetric (SWV) quantification
were chosen by studying the variation of the peak current
(Ip) with the square wave frequency ( f ), pulse amplitude
(E s) and ionic strength (I). The system was optimised,
particularly in respect of maximum peak current and
reproducibility.
The pH was measured using a Metrohm E-520 pHmeter and a Metrohm glass electrode.
The HPLC reference method(7-8) was performed using
a Sykam model A 1210 liquid chromatograph (Sykam,
Germany), equipped with an UV detector (λ = 203 nm)
model 3200. Separation of sample components was
accomplished at room temperature by gradient elution
using a Nucleosil 120-5 C18 column (250 × 4.6 mm, 5 μm
particle size, Macherey-Nagel, Germany). The mobilephase was 20 mM phosphate buffer pH 3.8 - acetonitrile, at
a flow rate of 1.0 mL per minute. The acetonitrile content
of the mobile phase was increased linearly from 25% to
40% during the first 10 min and then to 44% in 8 min.
II. Chemicals
Fluoxetine hydrochloride was provided by Merck
Farma (Lisboa, Portugal). Analytical grade reagents
purchased from Merck (Dar mstadt, Ger many) were
used without additional purification. Deionised water
(conductivity < 0.1 μS cm -1) was used throughout the
experiments. Buffer solutions employed for voltammetric
determinations were 0.2 M in the pH range 1.2 - 12.2.

HPLC-grade acetonitrile was obtained from Merck.
Phosphate buffer 20 mM was prepared in water and
the pH was adjusted to 3.8 with 10% orthophosphoric
acid. Prior to use, the solvents were filtered and air was
removed with helium.
A standard stock solution of fluoxetine (1 mM) was
prepared in deionised water. Standard solutions were
prepared in the voltammetric cell, adding accurate volumes
of the stock standard solution to the selected borate pH 9
supporting electrolyte in order to obtain concentrations
between 10 and 16 μM. The calibration curve for SWV
analysis was constructed by plotting the peak current
against the fluoxetine concentration (10.0, 11.5, 13.0, 14.5
and 16.0 μM). The limit of quantification (LOQ) and the
limit of detection (LOD) were calculated according to
USP guidelines(8). A S/N ratio of ten and three was used
respectively. Method precision was checked at different
days, within day (n = 5) and between days (n = 5) for three
different concentrations. The accuracy of the proposed
method was determined by comparing the results obtained
with those from reference methods(7-8).
III. Pharmaceutical Dosage form Assay Procedure
Fluoxetine content was determined in commercial
formulations available in Portugal; each capsule contains
20 mg of fluoxetine and the oral solution holds 20 mg per
5 mL of fluoxetine.
The average mass of ten capsules was determined. The
capsule contents were emptied as completely as possible.
An adequate amount of this powder equivalent to 1 mM was
weighed and dissolved with deionised water. The solution
was filtered to remove any remaining insoluble matter.
Working solutions of the pharmaceutical formulations
were prepared exactly as the standard solutions. A suitable
volume of oral solution was just diluted with water to
achieve the appropriate concentration.

RESULTS AND DISCUSSION
As no electrochemical data was available concerning
its oxidative behaviour, the electrochemical oxidation of
fluoxetine was studied in a broad pH range (1.2 – 12.2)
using a glassy carbon electrode. The differential pulse
voltammetric (DPV) behaviour of f luoxetine yielded
one anodic wave starting at pH 6 (Figure 2). As the pH
increase, a second poorly resolved wave appears at pH 8
(Figure 2). The peak potential (Ep) of the oxidation process
moved to less positive potential by raising the pH (Figure
3). The influence of pH on the fluoxetine peak current at
a glassy carbon electrode was also studied. The Ip versus
pH plot shows that peak current reaches a maximum value
at pH 9 (Figure 3). The experimental results showed that
shapes of the curves were better defined in borate buffer
pH 9 than in ammonia or Britton-Robinson buffers. Hence,
this electrolyte was used throughout this study.
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The cyclic voltammetric behaviour of f luoxetine at
pH 9 presented one well-defined wave at Ep = + 0.90 V.
Cyclic voltammetric measurements showed an irreversible
nature of the oxidation process, since no reduction wave
was observed on the cathodic branch. It was also observed
that at the second and higher cycles the fluoxetine current
intensity decreased. This occurrence could be attributed
to the adsorption of the oxidation products on the electrode
surface. Scan rate studies were carried out to assess
whether the oxidation process at the glassy carbon electrode
was under diffusion or adsorption control. The scan rate
(ν) varied from 10 to 1000 mV s-1 in 100 μM solution of
fluoxetine. From the dependence of peak current on sweep
rate, it is possible to conclude that the process is diffusion
controlled between 10 and 250 mV s-1. A plot of d log Ip
/ d log ν over this scan range gave a straight line with a
slope of 0.58, which also indicates a diffusion-controlled

process(14). The peak potential was shifted to more positive
values on increasing the scan rate, which also confirms the
irreversible nature of the oxidation process.
In order to prevent adsorption of f luoxetine and/or
its oxidation products on the electrode surface, a study
on the effect of the addition of different percentages
of the surfactant, Tween 20, was carried out. The use
of low percentages of the surfactant did not eliminated
completely the adsor ption effects observed for high
concentrations of f luoxetine. On the contrary, at high
percentages adsorption of the surfactant itself on the
electrode surface led to a diminution of the peak current,
despite the greater reproducibility obtained. The best
results were obtained for the addition of 0.5% of Tween 20
to the solution.
I. Analytical Application of the Proposed Method
A quantitative analytical method was developed
based on the voltammetric study of fluoxetine. The best
ratio of the peak to background currents was obtained
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Figure 2. Differential pulse voltammograms of a 100 μM solutions
of fluoxetine in (—) pH 6 phosphate buffer, (---) pH 7 phosphate
buffer, (-∙-∙-) pH 8 phosphate buffer and (∙∙∙∙∙) pH 9 borate buffer.
Scan rate 5 mV s-1.
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Figure 3. Plots of Ep (filled symbols) and Ip (open symbols) vs.
pH from differential pulse voltammograms of 100 μM solutions
of fluoxetine in 0.2 M ionic strength buffer electrolyte. Scan rate
5 mV s -1.
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Figure 4. Successive square wave voltammograms, in pH 9 borate
buffer electrolyte, of standard solutions of fluoxetine: A – 0.0, B –
10.0, C – 11.5, D – 13.0, E – 14.5 and F – 16.0 μM. Frequency 200
Hz; pulse amplitude 50 mV.
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using square wave voltammetry. This technique had also
originated sharper and better defined peaks resulting
in improved resolution. Optimisation of the SW V
parameters regarding peak definition and current was
accomplished using f = 200 Hz, Es = 50 mV and I = 0.2 M
(see Experimental section).
S q u a r e w ave volt a m m og r a m s r e c o r d e d w it h
increasing amounts of f luoxetine showed that the peak
current increased linearly with increasing concentration
(Figure 4). A linear relation between peak current and
fluoxetine concentration was observed in the range 10 to
16 μM. The characteristics of the calibration plots are
summarized in Table 1. The limit of detection (LOD) and
the limit of quantification (LOQ), calculated according to
USP guidelines [8], were 1.0 and 7.1 μM, respectively.
The precision of the method was evaluated at three
levels of concentration (10, 13 and 16 μM) (results shown
in Table 1). Specificity of the optimized procedure for
the assay of f luoxetine was examined through recovery
trials, in the presence of excipients (e.g. starch, lactose,
sucrose) at concent rations that can be found in the
for mulations. The results indicated the absence of
significant interference from any of the excipients found
in the pharmaceutical formulations tested. On the basis
of these results, the proposed method was applied to the
determination of fluoxetine in commercial capsules and
oral solutions. To evaluate the accuracy of the proposed
technique, the results were compared with those obtained
by the reference method(8) (Table 2).
The F- and Student t-test were carried out on the data
and statistically examined the validity of the obtained
results (Table 2). At the 95% confidence level, the values
of t- and F-tests were less than the theoretical values

Table 1. Linearity range, quantification and detection limits and
intra- and inter-day repeatability for determination of fluoxetine
using the square wave voltammetric method (SWV).

showing that there are no significant differences between
the proposed and reference methods.

CONCLUSIONS
T h is st udy h a s show n t h at f luoxet i ne ca n b e
deter mined by using the square wave voltammetric
technique on the basis of its oxidation process at a glassy
carbon electrode. The method has been successfully
applied to t he d i rect deter m i nat ion of f luoxet i ne,
without complex pre-treatment of the samples other than
dissolution or dilution, in pharmaceutical formulations
with adequate reproducibility and sensitivity.
The reported technique constitutes an alternative
method that can be implemented for routine analysis of
fluoxetine in pharmaceutical formulations. Moreover, the
results obtained outlook the possibility of development
of a successful HPLC strategy based on electrochemical
detection that is ideal for therapeutic drug monitoring
purposes and to study the metabolism of the drug, which
could enable the simultaneous determination of fluoxetine
and its metabolites in biological matrixes.
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Table 2. Application of the square wave voltammetric method
(SW V ) t o t he det e r m i n at ion of f luoxet i ne i n com me rcial
pharmaceutical preparations.

SWV
Linearity range (μM)

10 - 16

Calibration graph (n = 5)
Intercept (μA)
Slope (mA μM-1)
Correlation coefficient
Standard error of intercept
Standard error of slope

0.023
2.84
0.995
0.03
0.06

a

a

SWVa

Reference method (HPLC)a

Fluoxetine Irex®
tb
Fc

19.6 ± 0.4
1.4
1.6

20.2 ± 0.5

Fluoxetine Merck®
tb
Fc

20.2 ± 0.9
0.7
1.0

19.8 ± 0.9

Psipax®
tb
Fc

19.9 ± 0.9
0.4
2.2

19.7 ± 0.6

Formulation

Intra-day precision (n = 5)
10 μM
13 μM
16 μM

2.3
1.6
1.8

20.1 ± 0.9
1.2
1.0

19.4 ± 0.9

Inter-day precision (n = 5)a
10 μM
13 μM
16 μM

Nodepe ®
tb
Fc

3.0
2.1
1.8
1.0

20.5 ± 0.8
0.3
1.3

20.7 ± 0.9

LOD (μM)

Prozac ®
tb
Fc

LOQ (μM)

7.1

 recision as coefficient of variation (CV, %) = standard deviation
P
divided by mean measured concentration × 100.

a

 ean and standard deviation of five determinations for different
M
samples (mg/tablet or mg/5 mL).
b
Tabulated t-value for P = 0.05 and eight degrees of freedom is 2.31.
c
Tabulated F-value for P = 0.05 and f1 = f 2 = 4 is 6.39.
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